Literature DB >> 22054278

Romiplostim in chronic liver disease with severe thrombocytopenia undergoing an elective invasive procedure.

José Castellote, Anna Girbau, Claudia Arajol, Xavier Xiol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22054278     DOI： 10.4321/s1130-01082011001000015

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN： 1130-0108            Impact factor:   2.086


× No keyword cloud information.
  3 in total

Review 1.  Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures.

Authors:  Paolo Gallo; Francesca Terracciani; Giulia Di Pasquale; Matteo Esposito; Antonio Picardi; Umberto Vespasiani-Gentilucci
Journal:  World J Gastroenterol       Date:  2022-08-14       Impact factor: 5.374

Review 2.  A Review of Romiplostim Mechanism of Action and Clinical Applicability.

Authors:  James B Bussel; Gerald Soff; Adriana Balduzzi; Nichola Cooper; Tatiana Lawrence; John W Semple
Journal:  Drug Des Devel Ther       Date:  2021-05-26       Impact factor: 4.162

Review 3.  Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.

Authors:  Raoel Maan; Robert J de Knegt; Bart J Veldt
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.